30 results on '"Morra, Enrica"'
Search Results
2. Should a Positive Direct Antiglobulin Test Be Considered a Prognostic Predictor in Chronic Lymphocytic Leukemia?
3. Fludarabine, Cyclophosphamide, and Rituximab in Salvage Therapy of Waldenström's Macroglobulinemia.
4. Report From the Sixth International Workshop on Waldenström's Macroglobulinemia.
5. Fludarabine-Based Combination Therapies for Waldenström's Macroglobulinemia.
6. Cryoglobulinemia.
7. Update on Recommendations for Assessing Response from the Third International Workshop on Waldenström's Macroglobulinemia.
8. Clinical Characteristics and Outcome of Immunoglobulin M–Related Disorders.
9. Prognostic Factors for Transformation in Asymptomatic Immunoglobulin M Monoclonal Gammopathies.
10. Microarray Demonstrates Different Gene Expression Profiling Signatures Between Waldenström Macroglobulinemia and IgM Monoclonal Gammopathy of Undetermined Significance.
11. Factors predicting transformation of asymptomatic IgM monoclonal gammopathy.
12. Treatment of venous thromboembolism in Northern Italy: A population-based study from 2013 to 2018.
13. The influence of disease and comorbidity risk assessments on the survival of MDS and oligoblastic AML patients treated with 5-azacitidine: A retrospective analysis in ten centers of the “Rete Ematologica Lombarda”.
14. Current management of CML patients: Summary of the Italian Consensus Meeting held in Rome, April 11–12, 2013.
15. Hematological improvement during iron-chelation therapy in myelodysplastic syndromes: The experience of the “Rete Ematologica Lombarda”.
16. Regeneration-associated WNT Signaling Is Activated in Long-term Reconstituting AC133bright Acute Myeloid Leukemia Cells.
17. Down-regulation of MicroRNAs 222/221 in Acute Myelogenous Leukemia with Deranged Core-Binding Factor Subunits.
18. Flow cytometry vs cytomorphology for the detection of hematologic malignancy in body cavity fluids
19. Twice daily fludarabine/Ara-C associated to idarubicin, G-CSF and ATRA is an effective salvage regimen in non-promyelocytic acute myeloid leukemia
20. Prognostic value of circulating CD34+ cells in myelodysplastic syndromes
21. Outcome of hyperleukocytic adult acute myeloid leukaemia: A single-center retrospective study and review of literature
22. STI 571 inhibition effect on KITAsn822Lys-mediated signal transduction cascade
23. Imatinib mesylate in the treatment of Core Binding Factor leukemias with KIT mutations: A report of three cases
24. Interphase fluorescence in situ hybridization analysis of del(11)(q23) and del(17)(p13) in chronic lymphocytic leukemia: a study of 40 early-onset patients
25. Plerixafor and G-CSF for PBSC mobilization in patients with lymphoma who failed previous attempts with G-CSF and chemotherapy: A REL (Rete Ematologica Lombarda) experience
26. Total serum tryptase: A predictive marker for KIT mutation in acute myeloid leukemia
27. Corrigendum to ‘Hematological improvement during iron-chelation therapy in myelodysplastic syndromes: The experience of the “Rete Ematologica Lombarda”’ [Leuk Res 37 (2013) 1233–1240].
28. Erythroleukemia presenting with myeloid sarcoma of the lung as detected by immunophenotypic analysis of bronchoalveolar lavage fluid
29. Automated APTT cycle for the rapid identification of plasma prekallikrein deficiency
30. Long-term outcome in relapsed and refractory multiple myeloma treated with thalidomide. Balancing efficacy and side-effects
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.